Reducing Time to Market for Pharma Companies with Rapid Payer Response and Baiju Aurora, CEO of MAT

Typically, it takes several months for third-parties and consultants in the life sciences industry to get data back to pharma companies with payer research. Today's guest is Baiju Aurora, CEO of Market Access Transformation (MAT) is shrinking getting payer response research to a few days. Baiju has led the MAT team for more than five years and their first product, Rapid Payer Response, provides pharma companies payer research in only a few days from their payer network. Baiju’s career has spanned pricing, market access, health economics, and outcomes research for bio pharma, medical device, and diagnostics companies.Key Takeaways:Embrace unexpected clientsIndustry trends in pharma, including consolidation, execution, and how faster market research can propel pharma companies forwardConsider building a company with profitability first in mind rather than scale and growthShow Notes: Market Access Transformation (MAT) - Rapid Payer ResponseBaiju Aurora on LinkedInThe Physician Payments Sunshine ActFood Safety Preventive Controls Alliance (FSPCA)General Data Protection Regulation (GDPR)European Pharmaceutical Market Research Association (EphMRA)U.S. Food and Drug Administration (FDA)Application to be on the show: From Lab to LaunchQualioMusic by keldezQualio website:https://www.qualio.com/Previous episodes:https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez